184 related articles for article (PubMed ID: 34456079)
1. Is the addition of extranodal extension and lymph node yield of pN0 to the lymph node ratio useful as a prognostic parameter for patients with oral squamous cell carcinoma?
Yamagata K; Fukuzawa S; Uchida F; Okubo-Sato M; Ishibashi-Kanno N; Bukawa H
Br J Oral Maxillofac Surg; 2021 Oct; 59(8):941-946. PubMed ID: 34456079
[TBL] [Abstract][Full Text] [Related]
2. Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma.
Farrokhian N; Holcomb AJ; Dimon E; Karadaghy O; Ward C; Whiteford E; Tolan C; Hanly EK; Buchakjian MR; Harding B; Dooley L; Shinn J; Wood CB; Rohde S; Khaja S; Parikh A; Bulbul MG; Penn J; Goodwin S; Bur AM
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):947-955. PubMed ID: 36074415
[TBL] [Abstract][Full Text] [Related]
3. Prognostic capacity of the weighted lymph node ratio in head and neck squamous cell carcinoma patients treated with salvage neck dissection.
Neumann ED; Sansa A; Casasayas M; Gutierrez A; Quer M; León X
Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):4005-4010. PubMed ID: 33452917
[TBL] [Abstract][Full Text] [Related]
4. Weighted lymph node ratio: New tool in the assessment of postoperative staging of the neck dissection in HPV-negative head and neck squamous cell carcinoma patients.
León X; Neumann E; Gutiérrez A; García J; López M; Quer M
Head Neck; 2020 Oct; 42(10):2912-2919. PubMed ID: 32588930
[TBL] [Abstract][Full Text] [Related]
5. Is Lymph Node Ratio a Prognostic Factor for Patients With Oral Squamous Cell Carcinoma?
Yamagata K; Fukuzawa S; Kanno N; Uchida F; Yanagawa T; Bukawa H
J Oral Maxillofac Surg; 2019 Jul; 77(7):1510-1519. PubMed ID: 30822404
[TBL] [Abstract][Full Text] [Related]
6. Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.
Hosni A; McMullen C; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; Weinreb I; de Almeida JR; Brown DH; Irish JC; O'Sullivan B; Goldstein DP; Hope A
Radiother Oncol; 2017 Aug; 124(2):225-231. PubMed ID: 28838425
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Involvement of Lymph Node Density in Oral Squamous Cell Carcinoma. A New Predictive Model.
Verde-Sánchez L; Capote AL; Sanz-García A; Brabyn P; Rodríguez-Campo FJ; Naval Gías L
J Oral Maxillofac Surg; 2023 Mar; 81(3):358-369. PubMed ID: 36502856
[TBL] [Abstract][Full Text] [Related]
8. Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma.
Arun I; Maity N; Hameed S; Jain PV; Manikantan K; Sharan R; Arun P
Head Neck; 2021 Feb; 43(2):520-533. PubMed ID: 33021340
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lymph node involvement in oral squamous cell carcinoma.
Voss JO; Freund L; Neumann F; Mrosk F; Rubarth K; Kreutzer K; Doll C; Heiland M; Koerdt S
Clin Oral Investig; 2022 Nov; 26(11):6711-6720. PubMed ID: 35895143
[TBL] [Abstract][Full Text] [Related]
10. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.
Spoerl S; Gerken M; Mamilos A; Fischer R; Wolf S; Nieberle F; Klingelhöffer C; Meier JK; Spoerl S; Ettl T; Reichert TE; Spanier G
Clin Oral Investig; 2021 Apr; 25(4):1705-1713. PubMed ID: 32754787
[TBL] [Abstract][Full Text] [Related]
11. Comparing prognostic utility between the 8th edition of TNM staging system and the lymph node ratio for oral squamous cell carcinoma.
Beltramini GA; Belloni LM; Fusco N; Sacconi A; Muti P; Baj A; Bolzoni AR; Giannì AB
Head Neck; 2021 Oct; 43(10):2876-2882. PubMed ID: 34115912
[TBL] [Abstract][Full Text] [Related]
12. Potential of lymph-node ratio as a prognostic factor for patients with oral squamous cell carcinoma.
Tomo S; Araújo WAF; de Castro TF; Neto SC; Collado FU; Biasoli ÉR; Bernabé DG; Miyahara GI
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e814-e821. PubMed ID: 35998818
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of lymph node ratio in patients with squamous cell carcinoma of the floor of the mouth.
Liu XC; Ma SR; Shi S; Zhao YF; Jia J
Int J Oral Maxillofac Surg; 2022 Mar; 51(3):307-313. PubMed ID: 34281747
[TBL] [Abstract][Full Text] [Related]
14. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
[TBL] [Abstract][Full Text] [Related]
15. Lymph node ratio as a survival predictor for head and neck squamous cell carcinoma with multiple adverse pathological features.
Tsai MH; Chuang HC; Chien CY; Huang TL; Lu H; Su YY; Yang CH; Lai CC; Tsai WL; Lin YT; Fang FM
Head Neck; 2023 Aug; 45(8):2017-2027. PubMed ID: 37296517
[TBL] [Abstract][Full Text] [Related]
16. Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
Wang J; Liu Y; Shayan G; Ma Y; Yi J
Radiother Oncol; 2022 Jul; 172():83-90. PubMed ID: 35568286
[TBL] [Abstract][Full Text] [Related]
17. Lymph node level ratio as a predictor of survival in oral cavity squamous cell carcinoma.
Dermody SM; McMichael BM; Bellile E; Marchiano EJ; Chinn SB
Oral Oncol; 2023 Nov; 146():106572. PubMed ID: 37742470
[TBL] [Abstract][Full Text] [Related]
18. Influence of different methods for classification of lymph node metastases on the survival of patients with oral squamous cell carcinoma.
Tomo S; de Castro TF; Araújo WAF; Collado FU; Neto SC; Biasoli ÉR; Bernabé DG; Miyahara GI
J Stomatol Oral Maxillofac Surg; 2023 Apr; 124(2):101311. PubMed ID: 36261061
[TBL] [Abstract][Full Text] [Related]
19. Impact of lymph node ratio on survival and recurrence outcomes in oral squamous cell carcinoma.
Mamic M; Lucijanic M; Lorencin M; Suton P; Luksic I
Int J Oral Maxillofac Surg; 2022 Oct; 51(10):1257-1263. PubMed ID: 35101318
[TBL] [Abstract][Full Text] [Related]
20. Association between lymph node ratio and survival outcomes in patients with oral squamous cell carcinoma.
Haraguchi K; Habu M; Takahashi O; Tominaga K; Yoshioka I; Sasaguri M
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101816. PubMed ID: 38458548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
